智通财经APP讯，亚虹医药(688176.SH)发布公告，近日，公司产品APL1702用于治疗宫颈高级别鳞状上皮内病变(High-Grade Squamous Intraepithelial Lesion, ...

Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...

11月1日，国际期刊Nature communications在线发表了中国科学院上海营养与健康研究所钱友存研究组题为“Dietary nucleic acids promote oral tolerance through innate sensing pathways in mice” 的最新研究成果。该研究发现饮食来源的核酸可以在稳态条件下促进小鼠小肠中天然上皮内淋巴细胞（natural ...

CIN = cervical intraepithelial neoplasia; ASC-US=atypical cells of undetermined significance; ASC-H, atypical cells of undetermined significance, cannot exclude HSIL; LSIL, low-grade squamous ...

The Papanicolaou (Pap) smear is commonly used to screen for cervical cancer and since its introduction in organized screening programmes in resource-rich countries it has been successful in ...

证券之星消息，2024年11月5日亚虹医药（688176）发布公告称华鑫医药于2024年11月5日调研我司。 具体内容如下： 问：交流的主要及答复内容： 答：交流的主要问题及复内容 公司介绍了企业情况、公司主要业务进展、主要财务情况以及未来发展规划。 问1PL-1702进展如何了？什么时候获批？

England’s routine school-based human papillomavirus (HPV) vaccination programme is delivering greatly reduced rates of cervical disease and is helping towards the reduction of inequalities between ...

Dupixent demonstrated an 86% reduction in peak oesophageal intraepithelial eosinophil count from baseline compared to a 21% ...

EMA approves Dupixent to treat eosinophilic esophagitis in children as young as one year: Paris Thursday, November 7, 2024, 14:00 Hrs [IST] The European Medicines Agency has appro ...

Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...